Skip to main content

Research Repository

Advanced Search

Edward Roddy's Outputs (7)

P082 Nephrolithiasis associated with uricosuric therapies for the treatment of gout: a systematic review (2024)
Presentation / Conference
Dahanayake, C., Bajpai, R., Jordan, K. M., Lambie, M., & Roddy, E. (2024, April). P082 Nephrolithiasis associated with uricosuric therapies for the treatment of gout: a systematic review. Poster presented at British Society for Rheumatology Annual Conference 2024

Background/Aims
Uric acid nephrolithiasis is a recognised side-effect of uricosuric therapies and a contraindication to their use. The objective of this systematic review was to assess the incidence and risk of nephrolithiasis in people with gout re... Read More about P082 Nephrolithiasis associated with uricosuric therapies for the treatment of gout: a systematic review.

NEUROPATHIC PAIN IN FIRST METATARSOPHALANGEAL JOINT OSTEOARTHRITIS: FREQUENCY AND ASSOCIATED FACTORS (2022)
Presentation / Conference
Roddy. (2022, May). NEUROPATHIC PAIN IN FIRST METATARSOPHALANGEAL JOINT OSTEOARTHRITIS: FREQUENCY AND ASSOCIATED FACTORS. Presented at Australian Rheumatology Association 62nd Annual Scientific Meeting, Sydney, Adelaide, Brisbane, Hobart, Melbourne, Australia and Auckland, New Zealand

Aim: To determine whether neuropathic pain is a feature of first metatarsophalangeal (MTP) joint osteoarthritis (OA). Method: Ninety-eight participants (54 women and 44 men, mean age 57.4?years, standard deviation 10.3) with symptomatic radiographic... Read More about NEUROPATHIC PAIN IN FIRST METATARSOPHALANGEAL JOINT OSTEOARTHRITIS: FREQUENCY AND ASSOCIATED FACTORS.

Risk of Dementia in Patients with Gout and the Impact of Urate-Lowering Therapies: A Large Population-Based Cohort Study (2018)
Presentation / Conference
Crowley, L., Abdul Sultan, A., Roddy, E., Mallen, C., Protheroe, J., & Clarson, L. (2018, October). Risk of Dementia in Patients with Gout and the Impact of Urate-Lowering Therapies: A Large Population-Based Cohort Study. Poster presented at 2018 ACR/ARHP Annual Meeting

Background/Purpose: Evidence is conflicting concerning dementia risk in gout patients, with hyperuricaemia proposed to exert a neuroprotective effect. Serum urate (sUA) targets guiding urate-lowering therapies (ULT) are poorly evidenced-based and th... Read More about Risk of Dementia in Patients with Gout and the Impact of Urate-Lowering Therapies: A Large Population-Based Cohort Study.

Bisphosphonates and Risk of Acute Pseudogout: A Case-Control Study in the Clinical Practice Research Datalink (CPRD). (2014)
Presentation / Conference
Muller, S., Paskins, Z., Hider, S., Mallen, C., Roddy, E., & Bucknall, M. (2014, November). Bisphosphonates and Risk of Acute Pseudogout: A Case-Control Study in the Clinical Practice Research Datalink (CPRD). Poster presented at 2014 ACR/ARHP Annual Meeting, Boston, MA, usa

Background/Purpose: Acute pseudogout is the most dramatic clinical manifestation of calcium pyrophosphate crystal deposition (CPPD). CPPD is most commonly sporadic and age-related but can rarely occur secondary to metabolic diseases or a familial tra... Read More about Bisphosphonates and Risk of Acute Pseudogout: A Case-Control Study in the Clinical Practice Research Datalink (CPRD)..

THE EPIDEMIOLOGY OF MIDFOOT PAIN AND SYMPTOMATIC MIDFOOT OSTEOARTHRITIS: CROSSSECTIONAL FINDINGS FROM THE CLINICAL ASSESSMENT STUDY OF THE FOOT (2014)
Presentation / Conference
Thomas, M., Peat, G., Rathod, T., Moore, A., Menz, H. B., & Roddy, E. (2014, April). THE EPIDEMIOLOGY OF MIDFOOT PAIN AND SYMPTOMATIC MIDFOOT OSTEOARTHRITIS: CROSSSECTIONAL FINDINGS FROM THE CLINICAL ASSESSMENT STUDY OF THE FOOT. Poster presented at Annual Meeting of the British-Society-for-Rheumatology and British-Health-Professionals-in-Rheumatology

Comparative effectiveness of treatment options for subacromial shoulder conditions: A network meta-analysis
Presentation / Conference
Babatunde, Jordan, Van Der Windt, & Roddy. Comparative effectiveness of treatment options for subacromial shoulder conditions: A network meta-analysis. Presented at Global Evidence Summit 1017

Background: Subacromial shoulder conditions (SSCs) account for nearly 70% of all shoulder pain presentations to primary care, affecting one in three persons, half of whom still report pain and functional limitations 12 months post initial diagnosis.... Read More about Comparative effectiveness of treatment options for subacromial shoulder conditions: A network meta-analysis.